Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer

Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the paradigm in hematological malignancies treatment, driving an ever-expanding number of basic research and clinical trials of genetically engineering T cells to treat solid tumors. CAR T-cell therapies based on the antibodies target...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Caili, Ju, Dianwen, Zhang, Xuyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972219/
https://www.ncbi.nlm.nih.gov/pubmed/35372786
http://dx.doi.org/10.1093/abt/tbac006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972219/
https://www.ncbi.nlm.nih.gov/pubmed/35372786
http://dx.doi.org/10.1093/abt/tbac006

Ejemplares similares